Follow on Google News News By Tag * Pharmaceutical * Drug * Generic * Healthcare * Erosion * Regulatory * German * Infrastructure * Biosimilar * Therapy * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | New Market Report: Germany Pharmaceutical Market OverviewNew Pharmaceuticals market report from Datamonitor: "Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally"
Features and benefits * Overview of socioeconomic and demographic trends, healthcare system, regulation, pricing and reimbursement and intellectual property in Germany * Assesses the size of the Germany pharmaceutical market by prescribing setting, therapy area, leading brands and by leading companies * Examines the Germany generics and biosimilars landscape in terms of regulatory issues, level of penetration, key players and degree of brand erosion * Quantifies the R&D and manufacturing infrastructure for the leading pharmaceutical companies, including key metrics and domestic M&A analysis Highlights Low birth rate in Germany has led to a demographic crisis prompting the need for social security reforms despite the country's swift recovery from the economic downturn. Cuts are impacting the healthcare sector with pharmaceuticals also feeling the sting.New drug price negotiation requirements will give more leverage to health insurance funds. With an expected downward pressure on price, the impact will be felt domestically as well as internationally.Generics uptake is already high and the latest cost-containment measures including tendering contracts for generics have led to downward pricing spirals, negatively impacting the domestic generics industry. Biosimilars are also gaining ground and are becoming a real threat for biologics producers. Your key questions answered * Evaluate the evolving regulatory landscape and the impact of pricing and reimbursement controls on market access in Germany * Quantify the size and growth of the prescription pharmaceutical market in Germany, analyzing key therapy areas, brands and companies * Assess drivers and resistors of generic and biosimilars uptake in Germany For more information or to purchase this report, go to: - http://www.fastmr.com/ Partial Table of Contents: Executive Summary Introduction Strategic scoping and focus Key findings Germany - Socio-demographic and economic analysis Germany - Healthcare system and drug regulatory analysis Germany - Prescription pharmaceutical sales analysis Germany - Drug expiry analysis Germany - Drug Industry Infrastructure analysis Related reports Upcoming related reports 2. GERMANY - SOCIO-DEMOGRAPHIC AND ECONOMIC ANALYSIS Germany - Key findings Socio-demographic trends Socioeconomic trends Germany - Demographic trends Germany's population is declining leading to a potential demographic crisis The birth rate in Germany is among the lowest in all major markets Proportion of elderly individuals and life expectancy Germany - Disease burden Ischemic heart disease is the leading cause of death in Germany Death rate from smoking-related diseases in Germany is high Germany has the largest diabetic population in the EU Germany - Political climate The 2009 election resulted in changes in the ruling coalition government Germany - Economic climate Germany is recovering well from the global economic crisis, but economic divisions remain Germany's budget deficit is projected to reach almost 4.5% of GDP in 2010 Germany - Business environment Corporate income tax is reasonable in Germany Germany receives significant inward foreign direct investment The unemployment rate is expected to continue to rise post-recession 3. GERMANY - HEALTHCARE SYSTEM AND DRUG REGULATORY ANALYSIS Germany - Key findings Healthcare expenditure Insurance and healthcare system Regulatory issues Pricing and reimbursement Germany - Healthcare expenditure Germany has a higher than OECD average healthcare spend per capita, but spends less of its total healthcare expenditure on pharmaceuticals Germany - Insurance and healthcare system The statutory health insurance system dominates healthcare provision in Germany Private health insurance consists of comprehensive and supplementary schemes A raft of healthcare reforms have taken place in Germany Pharma hopes the reforms will dismantle the AOK monopoly Primary care versus hospital care in Germany Germany - Regulatory issues The Federal Institute for Drugs and Medical Products is the national drugs regulatory body in Germany Drug approval and regulatory processes in Germany Drugs typically launch in Germany following the US Intellectual property - patents are valid for 20 years from date of application in Germany Data exclusivity issues in Germany: the 8+2+1 rule Drug counterfeiting: Germany is a big parallel importer Germany - Pricing and reimbursement Key bodies influencing pricing and reimbursement in Germany Germany has implemented a number of health system reforms Pricing issues Reimbursement issues 4. GERMANY - PRESCRIPTION PHARMACEUTICAL SALES ANALYSIS Germany - Key findings Pharmaceutical market size Leading therapy areas Leading pharmaceutical brands Leading pharmaceutical companies Germany - Pharmaceutical market size Germany - Leading therapy areas CNS drugs held the largest share of the German market value Full Table of Contents is available at: -- http://www.fastmr.com/ About Datamonitor The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number